Article

Two retired executives join B&L board

Bausch & Lomb announced the addition of two members to its board of directors, J. Raymond Elliott and Richard F. Wallman.

Rochester NY-Bausch & Lomb (B&L) announced the addition of two members to its board of directors, J. Raymond Elliott and Richard F. Wallman.

From 2001 until his retirement in 2007, Elliott served as chairmen, president, and chief executive of orthopedic instrument manufacturer Zimmer Holdings Inc. Wallman was senior vice president and chief financial officer of aerospace equipment manufacturer Honeywell International Inc. from 1995 until his retirement in 2003.

For almost 30 years Elliott held general management positions in the health care, media, and consumer products industries. He also recently joined the board of Boston Scientific Corp.

Before his time at Honeywell, Wallman was vice president and controller at IBM Corp. and held leadership positions at Chrysler Corp.

These two executives join newly appointed board chairman Gerald Ostrov, chief executive officer Joseph P. Landy, Elizabeth H. Weatherman, and Sean D. Carney, all managing directors of Warburg Pincus LLC, and D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.